Deprecated: strpos(): Passing null to parameter #1 ($haystack) of type string is deprecated in /www/data/home2/proffx/public_html/wp-includes/functions.php on line 7300

Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in /www/data/home2/proffx/public_html/wp-includes/functions.php on line 2189

Deprecated: Creation of dynamic property WC_Gateway_PPEC_Plugin::$gateway_loader is deprecated in /www/data/home2/proffx/public_html/pub/plugins/woocommerce-gateway-paypal-express-checkout/includes/class-wc-gateway-ppec-plugin.php on line 371

Deprecated: Creation of dynamic property WC_Gateway_PPEC_Plugin::$admin is deprecated in /www/data/home2/proffx/public_html/pub/plugins/woocommerce-gateway-paypal-express-checkout/includes/class-wc-gateway-ppec-plugin.php on line 372

Deprecated: Creation of dynamic property WC_Gateway_PPEC_Plugin::$checkout is deprecated in /www/data/home2/proffx/public_html/pub/plugins/woocommerce-gateway-paypal-express-checkout/includes/class-wc-gateway-ppec-plugin.php on line 373

Deprecated: Creation of dynamic property WC_Gateway_PPEC_Plugin::$cart is deprecated in /www/data/home2/proffx/public_html/pub/plugins/woocommerce-gateway-paypal-express-checkout/includes/class-wc-gateway-ppec-plugin.php on line 374

Deprecated: Creation of dynamic property WC_Gateway_PPEC_Plugin::$ips is deprecated in /www/data/home2/proffx/public_html/pub/plugins/woocommerce-gateway-paypal-express-checkout/includes/class-wc-gateway-ppec-plugin.php on line 375

Deprecated: Creation of dynamic property WC_Gateway_PPEC_Plugin::$client is deprecated in /www/data/home2/proffx/public_html/pub/plugins/woocommerce-gateway-paypal-express-checkout/includes/class-wc-gateway-ppec-plugin.php on line 376
Patients may face barriers when trying to access new Alzheimer’s drug – Cincy Link
Cincy NewsNews

Patients may face barriers when trying to access new Alzheimer’s drug

A highly-anticipated Alzheimer's treatment is expected to become available this month. However, experts warn that accessibility will likely be a problem.

Lecanemab is the first treatment that appears to slow the progression of Alzheimer's disease. It's only for people in the early stages of cognitive decline.

Lecanemab is an infusion given every two weeks. It's estimated to cost $25,000 a year.

Those not wealthy or those not in clinical trials are expected to be left out.

"Another barrier to access stems from the fact Lecanemab is on accelerated FDA approval," said Dr. Michael Weiner.

He expects the FDA to announce whether the drug gets full approval later this year. If it is fully approved, the Center for Medicare Services will decide whether to cover it.

Once a drug is approved for Medicare, some insurance will pay for it and it is available through the Department of Veterans Affairs.

"I think those of us in the field, who see these patients and know what's going on and see the effects of this treatment, think that this treatment should definitely be available to the population, and we ought to try to find a way to pay for i.," Weiner said.

In clinical trials, the drug has been shown to slow cognitive decline by about 25%. Weiner said that could mean six to nine months of independence for patients and caregivers.




Source link

Show More

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Notice: ob_end_flush(): Failed to send buffer of zlib output compression (0) in /www/data/home2/proffx/public_html/wp-includes/functions.php on line 5427